Mankind Pharma partners with SpiceJet to elevate brand awareness

Mankind Pharma partners with SpiceJet to elevate brand awareness

Mankind Pharma partners with SpiceJet

Mankind Pharma, the global pharmaceutical firm, has announced its collaboration with SpiceJet – the Indian domestic airline – to elevate brand awareness.

This association marks the next step in propagating Mankind Pharma’s vision of ensuring international quality medicines to all.

Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma, shared, “At Mankind Pharma, our continuous endeavor has been to improve lives through groundbreaking healthcare solutions. Our goal is to enable access to international quality API medicines for everyone. This has led to the introduction of 120 DMF quality API in our medicines.”

This campaign aims to raise awareness about DMF-grade API medicines and the need for affordable yet international quality healthcare. Mankind hopes to capture even larger audiences and elevate their brand image through airport promotions and media spotlights. By leveraging this partnership, Mankind Pharma plans to create a lasting impact on consumers, reaffirming their position as a trusted pharmaceutical company in the Indian industry.

Debojo Maharshi, Chief Business Officer, SpiceJet, expressed, “On behalf of SpiceJet, I congratulate Mankind Pharma for their vision of introducing 120 DMF quality API medicines in India, which is a testament to their commitment to quality and excellence in the pharmaceutical industry. We are proud to once again partner with them in celebrating this achievement by wrapping two of our Boeing 737 aircraft in their livery. SpiceJet’s unique flying billboards have become an integral part of the promotions for various top brands, and we are happy to offer this innovative and effective medium to Mankind Pharma once again. We look forward to a long and fruitful association with them.”

Two SpiceJet planes displaying Mankind’s vision of providing international quality API medicines will take off on September 21. This will be a part of the larger campaign, which is aligned with one of the core focuses of the G20 India Presidency’s health initiatives, Universal Healthcare.